North Carolina

Four Duke professors took their research off-campus. Now they're reaping big rewards.

Wednesday, April 18, 2018

By Ray Gronberg - April 18, 2018

DURHAM - For a quartet of Duke University professors, graduation this spring isn't so much about caps, gowns and ceremony as it is about their off-campus biotech company taking off.

Their firm, Element Genomics, is the focus of what may ultimately become a $30 million acquisition by the Belgian pharmaceutical maker UCB. The deal comes about three years after Element's founding, and sets up an expanded collaboration that ultimately should yield new drugs.

To read the full article, please go to The Herald Sun.